ClinicalTrialsFinder
RecruitingNCT04682483

Cardiogenic Shock Working Group Registry

Sponsor

Tufts Medical Center

Enrollment

5,000 participants

Start Date

Dec 4, 2017

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock

Summary

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a large registry (data-collection study) for patients hospitalized with cardiogenic shock — a life-threatening condition where the heart suddenly cannot pump enough blood to meet the body's needs. The goal is to gather data to better understand treatments and outcomes. **You may be eligible if...** - You are hospitalized with cardiogenic shock, meaning your heart is not pumping properly and you have low cardiac output, low blood pressure, or high heart rate - You require at least one mechanical heart support device, a vasopressor, or an inotrope (medications or devices to support the heart) - If you recently had heart surgery, your shock must be present at least 72 hours after surgery **You may NOT be eligible if...** - You do not meet the specific criteria for cardiogenic shock as defined in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVasopressor

The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.

DRUGInotrope

Inotropes include dobutamine and milrinone.

DEVICEAcute Mechanical Circulatory Support Devices

Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.

Locations(16)

Cleveland Clinic Florida

Weston, Florida, United States

Northwestern Medicine

Chicago, Illinois, United States

University of Chicago

Chicago, Illinois, United States

Maine Medical Center

Portland, Maine, United States

Tufts Medical Center

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Hackensack Meridian Health

Hackensack, New Jersey, United States

Columbia University Irving Medical Center

New York, New York, United States

Providence St. Vincent Heart Clinic

Portland, Oregon, United States

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

University Of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Baylor Scott & White Advanced Heart Failure Clinic

Dallas, Texas, United States

University of Texas Medical Branch

Galveston, Texas, United States

Houston Methodist Hospital

Houston, Texas, United States

Inova Health System

Falls Church, Virginia, United States

University of Washington Medical Center

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04682483

Related Trials

Physiology of Unloading VA ECMO Trial

NCT063366551 location

Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock

NCT066382681 location

Altshock-2 REGISTRY

NCT042952521 location

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

NCT075271561 location

Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

NCT0734555911 locations